Trends in dementia incidence rates have important implications for planning and prevention. To better understand incidence trends over time requires separation of age and cohort effects, and few prior studies have used this approach.
T he world population older than 80 years is expected to increase more than 3-fold by 2050. 1 As the population ages, dementia and Alzheimer disease are consuming an increasing share of resources. Worldwide dementia prevalence is more than 47 million, and 7 million new cases develop each year. Dementia prevalence has been projected to double every 20 years and to reach 115 million by the year 2050. Prevalence of Alzheimer disease, the most common cause of dementia, is expected to reach 106 million by 2050. 2 The projected increase in dementia prevalence is driven by shifting demographics toward an older population. However, evidence suggests that dementia prevalence may have decreased in recent decades. 3 Decreasing incidence rates may explain the observed decreases in prevalence and would suggest a decrease in the projected burden of disease in the coming decades. Earlier studies [4] [5] [6] have found no significant changes in dementia incidence through the 1980s. Studies of more recent periods suggest that dementia incidence may be decreasing in the United States and Western Europe, [7] [8] [9] although the opposite trend has been reported for Wales. 10 Confirming that rates of dementia onset are decreasing has important implications for health care planning and resource allocation. Furthermore, a strong body of evidence supports the role of cardiovascular disease in cognitive decline and dementia, 11 and estimates indicate that more than half of all cases of Alzheimer disease are attributable to modifiable cardiovascular risk factors. 12 Establishing whether decreasing incidence is attributable to decreasing rates of cardiovascular disease would underscore the need for continuing prevention efforts that target vascular risk factors to reduce the burden of dementia. Since 1993, the Einstein Aging Study (EAS) has systematically recruited and followed up noninstitutionalized individuals 70 years and older from Bronx County, New York. 13 Incident dementia has consistently been ascertained using standard diagnostic criteria. Confirming temporal trends in incidence requires separation of age effects from cohort effects. Our goals were to determine whether there is evidence of a decrease in dementia incidence across sequential birth cohorts in the EAS population and to examine whether trends in the prevalence of cardiovascular disease explained the observed dementia trends. We thus conducted a cohort analysis by year of birth for the EAS cohort. This approach allowed for more precise separation of age and cohort effects than would analyses that compare cohorts recruited decades apart. 
Methods

Study Population
Follow-up Assessments
Annual assessments included a clinical neurologic examination, comprehensive neuropsychological assessments, medical history, blood pressure, anthropometrics, and psychosocial assessments. Prevalence of myocardial infarction, stroke, and diabetes was ascertained by self-report of physician diagnosis. Global cognitive performance was assessed using the BIMC test. 15 Depression was assessed using the Geriatric Depression Scale. 16 
Neurologic Examination and Dementia Diagnosis
The standardized neurologic examination was adapted from the Unified Parkinson's Disease Rating Scale. 17 The neurologist assigned a Hachinski Ischemic Score 18 and a Clinical Dementia Rating 19 and provided a clinical impression of the presence or absence of dementia.
Key Points
Question Has the incidence of all-cause dementia decreased in successive birth cohorts in a representative sample of community-residing adults in Bronx County, New York?
Findings Using a birth cohort analysis to disentangle age from cohort effects, this study found that dementia incidence rates decreased significantly among individuals born after 1929. Adjustment for age, sex, educational level, and prevalence of cardiovascular comorbidities did not explain the observed trend.
Meaning Additional studies are needed to determine whether decreasing dementia incidence will offset the demographic shift to older ages.
Dementia diagnosis was based on standardized clinical criteria from the DSM-IV 20 and required impairment in memory plus at least one additional cognitive domain, accompanied by evidence of functional decline. Diagnoses were assigned at consensus case conferences, which included comprehensive review of cognitive test results, relevant neurologic signs and symptoms, and functional status. Memory impairment was defined as scores of 1.5 SDs or more below the age-adjusted mean for the Logical Memory test 21 or a score of 24 or less on the Free and Cued Selective Reminding Test-Free Recall. 22 Functional impairment was determined using the Lawton Brody Scale, 23 clinical evaluation, and informant questionnaires. To ensure that diagnostic criteria were uniform over time, all individuals evaluated before the release of DSM-IV in 1994 were retrospectively reconferenced according to DSM-IV criteria. 20 A subset of individuals who participate in the EAS receive autopsies, providing an important quality control for diagnostic accuracy. A clinical diagnosis of dementia in the cohort has a positive predictive value of 96% for significant pathologic findings. 13 
Statistical Analysis
After exploratory analyses of cohort demographic characteristics and crude dementia incidence rates as a function of age and date of birth, we fit locally weighted scatterplot smoothing (LOESS) functions 24 using generalized additive models 25 to graphically identify patterns in the age-specific and birth cohort-specific dementia incidence rates. Poisson regression was used to model the incidence as a function of age, sex, race, educational level, and birth cohort, with change points used to identify the timing of noticeable increases or decreases in incidence. Profile likelihood 26 was used to estimate the change points, with a change point allowed to possibly fall any time between 1915 and 1935. The possibility of a second change point was considered by fitting a model with 2 change points and using likelihood ratio tests to select the best model. For the comparison of a model with 2 change points versus 1 change point, we used a P value of .025 as the threshold for selecting the larger model. We also considered a model with a loglinear trend in incidence as a function of birth year. Additional models included history of myocardial infarction, stroke, and diabetes to ascertain whether trends in prevalence of these conditions might account for changes in dementia incidence. All analyses were performed using SAS statistical software, version 9.4 (SAS Institute Inc).
Results
Among ) reflects that individuals were free of dementia at baseline, with slightly better baseline global performance among individuals born in more recent years, consistent with their younger age and higher educational level. Table 2 gives the crude dementia incidence rates as a function of age and dates of birth. Overall, the expected trend for increasing dementia incidence with increasing age was evident. Within each age range, dementia incidence rates were lower across sequential birth cohorts, particularly after 1929. Figure 1 displays LOESS plots of age-specific dementia incidence. The plot demonstrates the expected association of increasing incidence with increasing age. Figure 1 also shows a consistent pattern within each age group of decreasing incidence in sequential birth years, with an accelerated decrease in incidence rates apparent for those born in the middle to late 1920s.
To further explore this trend, we fit Poisson regression models with change points to identify birth years when there was a significant change in incidence rates. Models adjusted for age, sex, race, and educational level indicated a significant change point for individuals born after July 1929 (95% CI, June 1929 to January 1930). Model fit was not improved by addition of a second change point (likelihood ratio for the model with 1 change point was −647.671 and for 2 change points was −645.601; likelihood ratio test with 2 degrees of freedom, P = .13). Furthermore, a model for a simpler, log-linear trend in incidence by birth cohort did not fit the data as well as the To explore whether decreasing rates of cardiovascular disease and cardiovascular risk factors may have affected the dementia incidence rates, we explored age-specific trends for stroke, myocardial infarction, and diabetes by year (Figure 2) . The observed trends in the EAS cohort are consistent with national data from the United States showing reductions in cardiovascular disease rates across the past decades. 27, 28 The agespecific prevalence of myocardial infarction and stroke has decreased in our cohort across sequential birth cohorts. In contrast to the favorable myocardial infarction and stroke trends, we observed a notable increase in diabetes prevalence in later birth cohorts that is also consistent with national trends. How- Abbreviation: ND, no data (birth cohorts for which there were no observations in the specified age group). 
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Dementia Incidence in the Einstein Aging Study ever, when the Poisson models of dementia incidence by birth year were further adjusted for prevalence of myocardial infarction, stroke, or diabetes, the results remained unchanged and a significant decrease in dementia incidence among individuals born after mid-1929 remained.
Discussion
This cohort analysis of age-specific dementia incidence rates by birth year demonstrated decreased incidence of dementia in more recent birth cohorts among older individuals in Bronx County, New York. The decrease appears to have occurred for individuals born after mid-1929. The observed relative rate of incidence for those born after vs before July 1929 was 0.13 per 100 person-years. These results are consistent with previous studies that have suggested decreased dementia incidence in more recent periods [7] [8] [9] and no significant trends before the 1990s. [4] [5] [6] [7] 29 Our analytic approach differs from prior studies 8, 9 in that we examined incidence according to year of birth, whereas most prior studies 8, 9 have compared dementia rates in cohorts in a specified age bracket enrolled during different periods (eg, decades). Our birth cohort approach based on individual years of birth allows for a more precise separation of age and cohort effects, which might be difficult to disentangle when the age bands or enrollment periods studied are wide. Despite this difference, the EAS results are very consistent with earlier work, suggesting that any decrease in dementia incidence has been during more recent decades. The Rotterdam Study 9 reported a 25% decrease in allcause dementia rates between 1990 and 2000. The timing of this decrease coincides with our observed reduction in agespecific incidence among individuals born after 1929 because the earlier Rotterdam cohort was born between 1900 and 1930, whereas the later cohort was born between 1910 and 1940. Although the reduction in incidence did not reach statistical significance in the Rotterdam Study, the suggestion of a true decrease in dementia rates is strengthened by their observation of less cerebral small vessel disease and larger total brain volumes among individuals enrolled in the more recent period. 9 The EAS was unable to confirm whether cohort differences in brain pathologic findings may underlie the observed decrease in dementia incidence. More recent data from the Framingham cohort demonstrate a 20% decrease in dementia incidence rates since the late 1970s among those older than 60 years. 8 Similarly, Rocca et al 7 reported a small but statistically significant downward trend of 3% per year in all-cause and Alzheimer disease dementia among individuals aged 70 to 94 years during 1985 to 1994. A similar decrease in Alzheimer disease incidence was observed among individuals 65 years and older in the Chicago Health and Aging Project cohort between 1997 and 2008, although the trend did not reach statistical significance. 30 Earlier studies 5, 7 have found no decrease in dementia incidence rates for cohorts followed up before 1990. This finding is consistent with our results indicating no decrease in dementia incidence rates among individuals aged 70 to 84 years who were born from 1910 to 1930. Data from Rochester, Minnesota, indicate random fluctuations in dementia incidence before the mid-1980s, with no evidence of a decrease, 7 and suggest an increase in rates between 1965 and 1974. 5 There was no evidence of a birth cohort effect on dementia incidence for individuals born between 1885 and 1930, although birth cohorts after 1930 were not examined. 7 Consistent with our findings, a birth cohort analysis of 2 cohorts in western Pennsylvania demonstrated decreasing rates of cognitive decline with increasing age for individuals born between 1932 and 1943 vs earlier birth cohorts. 31 Prior studies 4, 5, [7] [8] [9] 30 have varied with regard to the method for ascertaining dementia incidence. The application of consistent diagnostic procedures over time is critical to the interpretation of temporal trends. A strength of our study is that dementia diagnoses were based on information from standardized study assessments and diagnostic criteria applied to all participants across the study period. Similarly, the Framingham, Rotterdam, and Chicago study results are based on clinical evaluations and diagnostic criteria applied uniformly over time. 8, 9, 30 In contrast, the studies 4,5,7 from the Rochester cohort relied on diagnostic codes from administrative databases. Despite these important differences, there appears to be consistent evidence across diverse cohorts that dementia incidence may be decreasing. Decreasing incidence rates are consistent with previous reports of decreased dementia prevalence during the past 10 to 20 years in the United States 3 and Western Europe. 32, 33 Decreased prevalence may result from decreasing rates of disease onset, increasing rates of cure or remission, or decreasing rates of survival after dementia diagnosis. Given the current lack of treatments to reverse Alzheimer disease or dementia 34 and data suggesting that survival among patients with dementia has increased, 35 it is likely that the favorable prevalence trends are attributable to decreased risk of dementia onset. Consistent with this hypothesis, a recent analysis 36 of administrative data from Canada found decreasing dementia incidence concurrent with increasing prevalence between 2005 and 2013. Some researchers have suggested that trends toward increasing level of education may underlie decreases in dementia incidence and prevalence. 3, 8 Although there was a shift toward higher education in our cohort, this trend did not explain our findings. Similarly, adjustment for education did not attenuate the cohort effects for decreased cognitive decline with age observed by Dodge et al. 31 Improved nutrition over successive birth cohorts might also have affected dementia risk. We were not able to assess this possibility because the EAS has not routinely ascertained dietary data. Vascular risk factors increase the risk of developing dementia, 11 and the incidence of stroke has decreased and the control of several cardiovascular risk factors has improved in the United States during the past several decades. 27 Although the decreasing dementia incidence that we observed may be partially related to decreases in the prevalence of cardiovascular comorbidities, these factors did not explain the observed results. Failure to detect an effect of these trends may have occurred because our analysis was based on selfreported medical history and may not reflect the overall burden of vascular disease in the population. We observed an adverse trend for the prevalence of diabetes that may portend increasing dementia incidence in the coming decades. The increasing prevalence of diabetes among EAS participants in later birth cohorts may reflect better treatment and survival among individuals with diabetes born in more recent decades. The trend is consistent with data on the worldwide increase in diabetes prevalence 37 and given evidence that links diabetes with dementia risk. This increase in diabetes prevalence may adversely affect dementia rates in the future.
We conducted a sensitivity analysis to determine whether our observed change point in dementia incidence was explained by the demographic shift in the racial/ethnic composition of the EAS cohort. In an analysis restricted to only white individuals, results were similar to those observed in the total sample, suggesting that shifting demographic characteristics did not explain our results.
Strengths and Limitations
A strength of our study is that the EAS is a community-based sample that is representative of the surrounding population. Community-based samples provide critical information regarding secular trends that cannot be assessed in referral samples of individuals with cognitive complaints. A limitation of our study is the small number of dementia cases for later birth years. Alzheimer disease is the leading cause of dementia in the elderly population, accounting for 60% to 80% of dementia cases. Thus, although a decrease in all-cause dementia is likely to reflect changes in Alzheimer disease rates, we could not address this issue because sample size constraints precluded our ability to analyze dementia subtypes. Nevertheless, the observed decrease in incidence after mid-1929 was robust in analyses that adjusted for differences in demographic characteristics and prevalence of cardiovascular comorbidity.
Conclusions
Future analyses in larger cohorts are required to confirm whether dementia incidence is decreasing. If the trend is confirmed, it remains to be seen whether decreasing dementia incidence will offset the ongoing demographic shift to older ages given that dementia incidence increases exponentially after 60 years of age. 38 In addition, despite advances in prevention and control of cardiovascular disease in recent decades, the future influence of the current diabetes epidemic on dementia incidence remains unknown. The observed trends highlight the need for continued efforts toward prevention and control of diabetes and vascular risk. 
ARTICLE INFORMATION
